A minimally-invasive heart valve procedure with a device made by Medtronic was superior to open surgery in extending the lives of patients with diseased aortic valves, according to a study funded by the company.
from WSJ.com: US Business http://ift.tt/1ocpsky
via IFTTT
from WSJ.com: US Business http://ift.tt/1ocpsky
via IFTTT
No comments:
Post a Comment